1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. METSERA INC.
Metsera Inc. XNAS: MTSR
27.09 -2.22 (-7.57%)
196.3K
XNAS Volume

XNAS 25 Jun, 2025 11:00 AM (EDT)



Insider Trading disclosures for Metsera Inc.

The latest disclosure was made by Brian Hubbard in Metsera Inc. where a trade of 120,000 Stock Option (Right to Buy) done was reported to US exchanges on May 20, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Brian Hubbard Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2025 120,000 120,000 - - Stock Option (Right to Buy)
Steven Marso Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2025 120,000 120,000 - - Stock Option (Right to Buy)
Christopher Whitten Bernard Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2025 348,750 348,750 - - Stock Option (Right to Buy)
Joshua Pinto Director Gift of securities by or to the insider at price $ 0.00 per share. 20 May 2025 148,953 0 - - Stock Option (Right to Buy)
Joshua Pinto Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2025 16,125 16,125 - - Stock Option (Right to Buy)
Joshua Pinto Director Gift of securities by or to the insider at price $ 0.00 per share. 20 May 2025 148,953 148,953 - - Stock Option (Right to Buy)
Christopher J. Visioli Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2025 150,000 150,000 - - Stock Option (Right to Buy)
Matthew Lang Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2025 46,875 46,875 - - Stock Option (Right to Buy)
Kristina M. Burow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2025 16,125 16,125 - - Stock Option (Right to Buy)
Clive A. Meanwell Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2025 32,250 32,250 - - Stock Option (Right to Buy)
Paul L. Berns Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2025 24,188 24,188 - - Stock Option (Right to Buy)
Jon P. Stonehouse Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2025 47,730 47,730 - - Stock Option (Right to Buy)
Kristina M. Burow Director, Ten Percent Owner 03 Feb 2025 19,933,333 0 - - Series Seed Preferred Stock
Paul L. Berns Director 03 Feb 2025 2,678,571 0 - - Series B Convertible Preferred Stock
Kristina M. Burow Director, Ten Percent Owner 03 Feb 2025 16,006,949 17,070,904 - - Common Stock
Kristina M. Burow Director, Ten Percent Owner 03 Feb 2025 15,000,000 0 - - Series A Convertible Preferred Stock
Kristina M. Burow Director, Ten Percent Owner 03 Feb 2025 2,678,571 0 - - Series B Convertible Preferred Stock
Kristina M. Burow Director, Ten Percent Owner 03 Feb 2025 7,523,682 7,523,682 - - Common Stock
Kristina M. Burow Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 18.00 per share. 03 Feb 2025 1,432,224 18,503,128 - 18 25,780,032 Common Stock
Kristina M. Burow Director, Ten Percent Owner 03 Feb 2025 2,678,571 0 - - Series B Convertible Preferred Stock
Kristina M. Burow Director, Ten Percent Owner 03 Feb 2025 15,000,000 0 - - Series A Convertible Preferred Stock
Kristina M. Burow Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 18.00 per share. 03 Feb 2025 789,998 8,313,680 - 18 14,219,964 Common Stock
Paul L. Berns Director 03 Feb 2025 15,000,000 0 - - Series A Convertible Preferred Stock
Paul L. Berns Director Purchase of securities on an exchange or from another person at price $ 18.00 per share. 03 Feb 2025 789,998 8,313,680 - 18 14,219,964 Common Stock
Paul L. Berns Director 03 Feb 2025 7,523,682 7,523,682 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures